BTG3 and metabolic dysfunction-associated steatohepatitis: In contrast, Kohut et al. observed no association between autoantibodies and the degree of liver inflammation, steatosis, or fibrosis, though they noted that combined ALT and ANA positivity could improve identification of patients at higher risk for NASH (29).